Physician profile
Irina Florentina Dragan
NPI 1902144678
$69,172.83
in general payments reported to CMS, 2019-2025
6 companies · $31K in 2025
The $31K reported for 2025 was more than what 99% of Periodontics providers received nationally (typical 2025 total: $111).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,165 · 2020: $35.55 · 2021: $41.18 · 2022: $562 · 2023: $24K · 2024: $4,019 · 2025: $31K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $32K · Travel and Lodging: $18K · Consulting Fee: $4,963 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,500 · Food and Beverage: $926.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $31,699.00 |
| Travel and Lodging | $18,281.57 |
| Consulting Fee | $4,963.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,500.00 |
| Food and Beverage | $925.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Geistlich Pharma, North America, INC. | $56,316.42 | 2021-2025 | Bio-Gide, Geistlich Bio-Gide, Bio-Oss |
| Kerecis Limited | $9,123.01 | 2019 | |
| Straumann USA LLC | $3,626.50 | 2021-2025 | |
| Biohorizons Implant Systems INC. | $49.59 | 2020-2023 | Biohorizons |
| Orapharma, A Division of Bausch Health US, LLC | $42.08 | 2019 | |
| Philips North America LLC | $15.23 | 2024 | (8614) Protectiveclean 4100-4300 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Irina Dragan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.